Lipomatous tumours

Current Diagnostic Pathology

Volumn 7, Issue 1, 2001, Pages 8-16

  Dei Tos, A P ^a  

^a Regional Hospital of Treviso   (Italy)

Author keywords

Atypical lipomatous tumour; Cytogenetics; Liposarcoma

Indexed keywords

ADIPOCYTE; CANCER CLASSIFICATION; CANCER GENETICS; CANCER RECURRENCE; CANCER RISK; CELL DIFFERENTIATION; CHROMOSOME 12; CHROMOSOME 2; CONFERENCE PAPER; HUMAN; KARYOTYPE; LIPOMA; LIPOSARCOMA; METASTASIS; MUSCLE TUMOR; MYXOSARCOMA; RECIPROCAL CHROMOSOME TRANSLOCATION; SPINDLE CELL;

EID: 0035074824     PISSN: 09686053     EISSN: None     Source Type: Journal    
DOI: 10.1054/cdip.2000.0056     Document Type: Conference Paper

References (56)

1. Soft tissue tumours
2. Histologic typing of soft tissue tumours
3. The role of cytogenetics in the classification of soft tissue tumours
4. Myolipoma of soft tissue
5. Chondroid lipoma. A unique tumor-simulating liposarcoma and myxoid chondrosarcoma
6. Extraskeletal chondroma with lipoblast-like cells
7. Extraskeletal myxoid chondrosarcoma: An immunohistochemical reappraisal of 39 cases
8. Unique cytological features and chromosome aberrations in chondroid lipoma: A case report based on fine needle aspiration cytology, histopathology, electron microscopy, chromosome banding and molecular cytogenetics
9. Liposarcoma. A study of 103 cases
10. Liposarcoma: The malignant tumour of lipoblasts
11. Well-differentiated inflammatory liposarcoma: An uncommon and easily overlooked variant of a common sarcoma
12. Lymphocyte-rich well-differentiated liposarcoma: Report of nine cases
13. Spindle cell liposarcoma: A hitherto unrecognized variant of well-differentiated liposarcoma: Analysis of six cases
14. Spindle-cell liposarcoma
15. Atypical lipoma, atypical intramuscular lipoma, and well differentiated retroperitoneal liposarcoma. A reappraisal of 30 cases formerly classified as well-differentiated liposarcoma
16. Atypical lipoma
17. Liposarcoma and atypical lipomatous tumours: A study of 66 cases followed for a minimum of 10 years
18. Well-differentiated liposarcoma (atypical lipoma) of deep soft tissue of the extremities, retroperitoneum and miscellaneous sites. A follow-up study of 92 cases with analysis of the incidence of dedifferentiation
19. Lipomatous tumours of soft tissue: An update
20. Liposarcoma: A study of 55 cases with a reassessment of its classification
21. Malignant (fibrous) histiocytoma of bone: Fact or fancy?
22. Dedifferentiated liposarcoma. A report of nine cases with a peculiar neurallike whorling pattern associated with metaplastic bone formation
23. Liposarcoma with meningothelial-like whorls: A study of 17 cases of a distinctive histological pattern associated with dedifferentiated liposarcoma
24. Dedifferentiated liposarcoma: A clinicopathologic analysis of 155 cases with proposal for an expanded definition of dedifferentiation
25. Well-differentiated liposarcoma of the retroperitoneum: A clinicopathologic analysis of 20 cases, with particular attention to the extent of low-grade dedifferentiation
26. Dedifferentiated liposarcoma. Clinicopathologic analysis of 32 cases suggesting a better prognostic subgroup among pleomorphic sarcomas
27. Correlation between clinicopathological features and karyotype in lipomatous tumours
28. Cytogenetic analysis of 46 pleomorphic soft tissue sarcomas and correlation with morphologic and clinical features: A report of the CHAMP study group. Chromosomes and Morphology
29. Molecular abnormalities of the p53 pathway in dedifferentiated liposarcoma
30. mdm2 gene amplification in bone and soft tissue tumours: Association with tumour progression in differentiated adipose tissue tumours
31. Molecular abnormalities of MDM2 and p53 genes in adult soft tissue sarcomas
32. Translocation t(12;16)(q13:p11) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis
33. Combined Morphologic and karyotypic study of 28 myxoid liposarcomas. Implications for a revised morphologic typing. A report from the CHAMP group
34. S-100 protein staining in liposarcoma. Its diagnostic utility in the high-grade myxoid (round cell) variant
35. The clinicopathologic spectrum of myxoid and round cell liposarcoma. A study of 95 cases
36. Myxoid/round cell liposarcoma of the extremities. A clinicopathologic study of 29 cases with particular attention to extent of round cell liposarcoma
37. Will we ever reliably predict prognosis in a patient with myxoid and round cell liposarcoma?
38. Pleomorphic liposarcoma: Clinicopathologic and prognostic analysis of 31 cases
39. Epithelioid variant of pleomorphic liposarcoma: A study of 12 cases of a distinctive variant of high-grade liposarcoma
40. Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains
41. Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours
42. HMGI(Y) and HMGI-C dysregulation: A common occurrence in human tumor
43. LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family
44. Hibernomas are characterized by rearrangements of chromosome bands 11q13-21
45. New discriminative chromosomal marker in adipose tissue tumors. The chromosome 8q11-q13 region in lipoblastoma
46. Correlation between clinicopathological features and karyotype in lipomatous tumors
47. Combined morphologic and karyotypic study of 59 atypical lipomatous tumours: Evaluation of their relationship and differential diagnosis with other adipose tissue tumours
48. Cytogenetic and fluorescence in situ hybridization investigation of ring chromosomes characterizing a specific pathologic subgroup of adipose tissue tumours
49. Coordinated expression and amplification of the MDM2, CDK4 and HMGI-C genes in atypical lipomatous tumours
50. Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcoma
51. Translocation t(12;16)(q13:p11) in myxoid liposarcoma and round cell liposarcoma: Molecular and cytogenetic analysis
52. Additional evidence of a variant translocation t(12;22) with EWS/CHOP fusion in myxoid liposarcoma: Clinicopathologic features
53. Trisomy 8 as a nonrandom secondary change in myxoid liposarcoma
54. Molecular aberrations of the GI-S cell cycle checkpoint in myxoid and round cell liposarcoma
55. Induction of solid tumor differentiation by the peroxisome proliferator-activated ligand troglitazone in patients with liposarcoma